NVDA
NVIDIA Corporation
NVDA has the edge over PRGS overall, supported by stronger modeled upside and stronger valuation.
PRGS
Progress Software Corporation
PRGS trails on the overall score without a compensating advantage in the available component scores.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
PRGS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Under pressure |
PRGS's profitability and cash flow are currently strong, and its revenue is stable, but its balance sheet is under pressure.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over PRGS in the historical PE scenario, which offers more potential upside but is not a forecast.
PRGS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.7x | $43.44 | — |
| Current | 20x | $43.44 | — |
| Cheap | 25x | $53.38 | +23% |
| Fair | 31x | $66.66 | +53% |
| Expensive | 38x | $81.69 | +88% |
Historical ranges are pointers, not guarantees.
PRGS's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 6.7x next year's earnings.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
PRGS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for PRGS, but weaker profitability.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over PRGS on earnings, with more consistent year-over-year improvement.
PRGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.46 | +198% |
| Q3 2026 | $2.17 | +101% |
| Q2 2026 | $2.06 | +60% |
| Q1 2026 | $1.95 | +54% |
| Q4 2025 | $1.66 | +7.8% |
| Q3 2025 | $1.08 | -43% |
| Q2 2025 | $1.29 | -22% |
| Q1 2025 | $1.27 | -18% |
| Q4 2024 | $1.54 | -1.9% |
PRGS earned $2.17 per share over the past year, up 101% from the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over PRGS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over PRGS on profitability, with a higher operating margin.
PRGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $246M | -1.5% |
| Q2 2026 | $253.5M | +6.8% |
| Q1 2026 | $247.8M | +4.1% |
| Q4 2025 | $252.7M | +18% |
| Q3 2025 | $249.8M | +40% |
| Q2 2025 | $237.4M | +36% |
| Q1 2025 | $238M | +29% |
| Q4 2024 | $215M | +21% |
PRGS's revenue is growing: $246M last quarter, down 1.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | +1.4 points |
| Q2 2026 | 18% | +1.6 points |
| Q1 2026 | 19% | +5.1 points |
| Q4 2025 | 15% | +5.2 points |
| Q3 2025 | 18% | -5 points |
| Q2 2025 | 16% | +0.8 points |
| Q1 2025 | 14% | -5.3 points |
| Q4 2024 | 10% | -2.7 points |
PRGS's operating margin was 19% last quarter, up 1.4 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over PRGS on cash flow, with more consistent year-over-year improvement.
PRGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $86.3M | +19% |
| Q2 2026 | $77M | +161% |
| Q1 2026 | $95.9M | +42% |
| Q4 2025 | $59.9M | +257% |
| Q3 2025 | $72.4M | +28% |
| Q2 2025 | $29.5M | -53% |
| Q1 2025 | $67.7M | -3.6% |
| Q4 2024 | $16.8M | -45% |
PRGS's free cash flow has been positive every quarter for seven years: $319M over the past year, up 71% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
PRGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2% | -832K shares |
| 1 year | -5.1% | -2.2M shares |
| 3 years | -7.8% | -3.5M shares |
| 5 years | -6.8% | -3M shares |
| Available history | -8.5% | -3.9M shares |
PRGS has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $16.9M |
| Q2 2026 | $34.7M |
| Q1 2026 | $20.4M |
| Q4 2025 | $40M |
| Q3 2025 | $15M |
| Q2 2025 | $20M |
| Q1 2025 | $30.1M |
| Q4 2024 | — |
PRGS spent $112M buying back its own shares over the past year, up 72% from the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over PRGS on leverage, with a lower net debt burden relative to earnings.
PRGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.5x | Elevated |
| Q2 2026 | 3.7x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 4.3x | High |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.9x | Elevated |
| Q1 2025 | 5.9x | High |
| Q4 2024 | -0.5x | Net Cash |
PRGS's net debt is about 3.5 years of its operating earnings (EBITDA), about the same as a year ago.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
PRGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 73.9 | Neutral |
PRGS's weekly RSI is 56 (neutral) and its Stochastic is 74 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
PRGS PE vs Technology Sector
| Metric | PRGS | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 28x | 28% below |
| PE % | 8 | 35 | 27 pts below |
PRGS has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
PRGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $41.9 | 3.7% above |
| 20 week MA | $41.5 | 4.7% above |
| 50 week MA | $37.8 | 15% above |
| 100 week MA | $45.5 | 4.5% below |
| 200 week MA | $51.1 | 15% below |
PRGS has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
PRGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.7 | $44.2 | +6% |
| 2021 | $44.2 | $48.3 | +9.3% |
| 2022 | $48.3 | $50.5 | +4.4% |
| 2023 | $50.5 | $54.3 | +7.6% |
| 2024 | $54.3 | $65.5 | +21% |
| 2025 | $65.5 | $43.5 | -34% |
| 2026 YTD | $43.5 | $43.4 | -0.2% |
PRGS has the edge over NVDA on returns for 2026, with the stronger performance.